Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 5, 2017
[ 11:47 AM ] - United States, WOPRAI
[ 11:47 AM ] - United States, WOPRAI
[ 11:47 AM ] - United States, WOPRAI
[ 11:47 AM ] - United States, WOPRAI
[ 11:47 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:46 AM ] - United States, WOPRAI
[ 11:45 AM ] - United States, WOPRAI
[ 11:45 AM ] - United States, WOPRAI
[ 11:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 2, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Hartaj Singh Upgraded (VRTX) to Buy on, Jun 2nd, 2017
Hartaj Singh of Oppenheimer, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy on, Jun 2nd, 2017.
Hartaj has made no other calls on VRTX in the last 4 months.
There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Hartaj
- Do Kim of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, March 29th, 2017
- Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy on, Friday, March 17th, 2017
